Nalaganje...
Targeted Therapies in NSCLC: Emerging oncogene targets following the success of EGFR
The diagnostic testing, treatment and prognosis of non-small cell lung cancer (NSCLC) has undergone a paradigm shift since the discovery of sensitizing mutations in the epidermal growth factor receptor (EGFR) gene in a subset of NSCLC patients. Several additional oncogenic mutations, including gene...
Shranjeno v:
| Main Authors: | , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2013
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4159759/ https://ncbi.nlm.nih.gov/pubmed/24565585 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1053/j.seminoncol.2013.12.006 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|